"We are an innovative research group serving the community in three locations, Athens, Huntsville, and Cullman. We participate in a wide range of clinical research studies to evaluate new pharmaceutical therapies and medical devices to improve the treatment of specific diseases."

During the past decade, North Alabama Research Center, LLC conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 16 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 13 clinical trials were completed. i.e. 92.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Alabama Research Center, LLC" #1 sponsor was "Pfizer" with 7 trials, followed by "Allergan" with 4 trials sponsored, "Phathom Pharmaceuticals, Inc." with 4 trials sponsored, "BioNTech SE" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Alabama Research Center, LLC" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator, "Pharm-Olam International" with 1 trials as a collaborator and "RTI Health Solutions" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "North Alabama Research Center, LLC" are "Gastroparesis" (4 trials), "Cardiovascular Disease" (3 trials), "Diabetes Mellitus" (3 trials), "COVID-19" (2 trials) and "Clostridium Difficile Infection" (2 trials). Many other conditions were trialed in "North Alabama Research Center, LLC" in a lesser frequency.

Most popular intervention types in "North Alabama Research Center, LLC" are "Drug" (21 trials), "Biological" (9 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Vonoprazan" (4 trials), "Relamorelin" (3 trials), "BNT162b2" (2 trials) and "Lansoprazole" (2 trials). Other intervention names were less common.

The vast majority of trials in "North Alabama Research Center, LLC" are 30 trials for "All" genders.

Currently, there are NaN active trials in "North Alabama Research Center, LLC". undefined are not yet recruiting, undefined are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in North Alabama Research Center, LLC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in North Alabama Research Center, LLC, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".